// App-Quantinova.ai

650 : T-DM1 in HER2-positive breast cancer brain metastases (BM).

Researchers

Presenter

  • Rupert Bartsch

Principal Investigators

  • Anna Sophie Berghoff

  • Karin Dieckmann

  • Katja Pinker

  • Christoph Zielinski

  • Guenther G. Steger

  • Matthias Preusser

  • Margareta Rudas

  • Elisabeth Bergen

  • Michael Gnant

Medical Centers

  • Department of Urology, Medical University Vienna, Vienna, Austria

  • Institute of Pathology, Medical University of Vienna, Vienna, AustriaComprehensive Cancer Center, Department of Surgery, Medical University of Vienna, Vienna, AustriaMedical University of Vienna, Vienna, Austria

  • Medical University of Vienna, and Initiative Leben mit Krebs, Vienna, Austria, Vienna, Austria

  • Institute of Neurology, Medical University of Vienna, Vienna, Austria

  • Department of Medicine I, Clinical Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  • Department for Medicine I/Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

  • Department for Radiation Therapy and Radiation Biology, Medical University of Vienna, Vienna, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Brain metastasis

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab emtansine

Outcome

  • Indeterminate

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved